Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Genmab AS (GMAB)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Genmab AS's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
29.28 +0.25    +0.86%
00:51:20 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 376,570
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 28.89 - 29.36
Genmab AS 29.28 +0.25 +0.86%

GMAB Balance Sheet

 
Featured here, the Balance Sheet for Genmab AS, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Collapse All
Period Ending: 2024
31/03
 2023
31/12
 2023
30/09
 2023
30/06
Total Current Assets 34369 33139 33027 29749
Cash and Short Term Investments 29584 28135 27525 24884
Cash - - - -
Cash & Equivalents 14670 14867 14273 10874
Short Term Investments 14914 13268 13252 14010
Total Receivables, Net 4679 4947 5432 4814
Accounts Receivables - Trade, Net 4679 4947 5432 4690
Total Inventory 106 57 70 51
Prepaid Expenses - - - -
Other Current Assets, Total - - - -
Total Assets 36680 35289 35238 31978
Property/Plant/Equipment, Total - Net 1860 1641 1651 1634
Property/Plant/Equipment, Total - Gross - 2317 - -
Accumulated Depreciation, Total - -676 - -
Goodwill, Net - - - -
Intangibles, Net 23 101 115 129
Long Term Investments 153 134 156 183
Note Receivable - Long Term - - - 124
Other Long Term Assets, Total - - - -
Other Assets, Total 10616 8652 8179 9530
Total Current Liabilities 2759 2484 2902 1993
Accounts Payable - - - -
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 92 90 83 82
Other Current liabilities, Total 2667 2394 2819 1911
Total Liabilities 4183 3679 4126 3223
Total Long Term Debt 918 680 710 721
Long Term Debt - - - -
Capital Lease Obligations 918 680 710 721
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 506 515 514 509
Total Equity 32497 31610 31112 28755
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 66 66 66 66
Additional Paid-In Capital 12520 12461 12452 12412
Retained Earnings (Accumulated Deficit) 19803 19023 18452 16165
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 108 60 142 112
Total Liabilities & Shareholders' Equity 36680 35289 35238 31978
Total Common Shares Outstanding 65.14 65.33 65.32 65.28
Total Preferred Shares Outstanding - - - -
* In Millions of DKK (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

GMAB Comments

Write your thoughts about Genmab AS
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email